2023-12-012024-11-302024-11-30false13716458CANNACARE CBD LTD2025-01-22falseiso4217:GBPxbrli:pure137164582023-12-01137164582024-11-30137164582023-12-012024-11-30137164582022-12-01137164582023-11-30137164582022-12-012023-11-3013716458bus:SmallEntities2023-12-012024-11-3013716458bus:AuditExempt-NoAccountantsReport2023-12-012024-11-3013716458bus:FullAccounts2023-12-012024-11-3013716458bus:PrivateLimitedCompanyLtd2023-12-012024-11-3013716458core:WithinOneYear2024-11-3013716458core:AfterOneYear2024-11-3013716458core:WithinOneYear2023-11-3013716458core:AfterOneYear2023-11-3013716458core:ShareCapital2024-11-3013716458core:SharePremium2024-11-3013716458core:RevaluationReserve2024-11-3013716458core:OtherReservesSubtotal2024-11-3013716458core:RetainedEarningsAccumulatedLosses2024-11-3013716458core:ShareCapital2023-11-3013716458core:SharePremium2023-11-3013716458core:RevaluationReserve2023-11-3013716458core:OtherReservesSubtotal2023-11-3013716458core:RetainedEarningsAccumulatedLosses2023-11-3013716458core:LandBuildings2024-11-3013716458core:PlantMachinery2024-11-3013716458core:Vehicles2024-11-3013716458core:FurnitureFittings2024-11-3013716458core:OfficeEquipment2024-11-3013716458core:NetGoodwill2024-11-3013716458core:IntangibleAssetsOtherThanGoodwill2024-11-3013716458core:ListedExchangeTraded2024-11-3013716458core:UnlistedNon-exchangeTraded2024-11-3013716458core:LandBuildings2023-11-3013716458core:PlantMachinery2023-11-3013716458core:Vehicles2023-11-3013716458core:FurnitureFittings2023-11-3013716458core:OfficeEquipment2023-11-3013716458core:NetGoodwill2023-11-3013716458core:IntangibleAssetsOtherThanGoodwill2023-11-3013716458core:ListedExchangeTraded2023-11-3013716458core:UnlistedNon-exchangeTraded2023-11-3013716458core:LandBuildings2023-12-012024-11-3013716458core:PlantMachinery2023-12-012024-11-3013716458core:Vehicles2023-12-012024-11-3013716458core:FurnitureFittings2023-12-012024-11-3013716458core:OfficeEquipment2023-12-012024-11-3013716458core:NetGoodwill2023-12-012024-11-3013716458core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3013716458core:ListedExchangeTraded2023-12-012024-11-3013716458core:UnlistedNon-exchangeTraded2023-12-012024-11-3013716458core:MoreThanFiveYears2023-12-012024-11-3013716458core:Non-currentFinancialInstruments2024-11-3013716458core:Non-currentFinancialInstruments2023-11-3013716458dpl:CostSales2023-12-012024-11-3013716458dpl:DistributionCosts2023-12-012024-11-3013716458core:LandBuildings2023-12-012024-11-3013716458core:PlantMachinery2023-12-012024-11-3013716458core:Vehicles2023-12-012024-11-3013716458core:FurnitureFittings2023-12-012024-11-3013716458core:OfficeEquipment2023-12-012024-11-3013716458dpl:AdministrativeExpenses2023-12-012024-11-3013716458core:NetGoodwill2023-12-012024-11-3013716458core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3013716458dpl:GroupUndertakings2023-12-012024-11-3013716458dpl:ParticipatingInterests2023-12-012024-11-3013716458dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3013716458core:ListedExchangeTraded2023-12-012024-11-3013716458dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3013716458core:UnlistedNon-exchangeTraded2023-12-012024-11-3013716458dpl:CostSales2022-12-012023-11-3013716458dpl:DistributionCosts2022-12-012023-11-3013716458core:LandBuildings2022-12-012023-11-3013716458core:PlantMachinery2022-12-012023-11-3013716458core:Vehicles2022-12-012023-11-3013716458core:FurnitureFittings2022-12-012023-11-3013716458core:OfficeEquipment2022-12-012023-11-3013716458dpl:AdministrativeExpenses2022-12-012023-11-3013716458core:NetGoodwill2022-12-012023-11-3013716458core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3013716458dpl:GroupUndertakings2022-12-012023-11-3013716458dpl:ParticipatingInterests2022-12-012023-11-3013716458dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3013716458core:ListedExchangeTraded2022-12-012023-11-3013716458dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3013716458core:UnlistedNon-exchangeTraded2022-12-012023-11-3013716458core:NetGoodwill2024-11-3013716458core:IntangibleAssetsOtherThanGoodwill2024-11-3013716458core:LandBuildings2024-11-3013716458core:PlantMachinery2024-11-3013716458core:Vehicles2024-11-3013716458core:FurnitureFittings2024-11-3013716458core:OfficeEquipment2024-11-3013716458core:AfterOneYear2024-11-3013716458core:WithinOneYear2024-11-3013716458core:ListedExchangeTraded2024-11-3013716458core:UnlistedNon-exchangeTraded2024-11-3013716458core:ShareCapital2024-11-3013716458core:SharePremium2024-11-3013716458core:RevaluationReserve2024-11-3013716458core:OtherReservesSubtotal2024-11-3013716458core:RetainedEarningsAccumulatedLosses2024-11-3013716458core:NetGoodwill2023-11-3013716458core:IntangibleAssetsOtherThanGoodwill2023-11-3013716458core:LandBuildings2023-11-3013716458core:PlantMachinery2023-11-3013716458core:Vehicles2023-11-3013716458core:FurnitureFittings2023-11-3013716458core:OfficeEquipment2023-11-3013716458core:AfterOneYear2023-11-3013716458core:WithinOneYear2023-11-3013716458core:ListedExchangeTraded2023-11-3013716458core:UnlistedNon-exchangeTraded2023-11-3013716458core:ShareCapital2023-11-3013716458core:SharePremium2023-11-3013716458core:RevaluationReserve2023-11-3013716458core:OtherReservesSubtotal2023-11-3013716458core:RetainedEarningsAccumulatedLosses2023-11-3013716458core:NetGoodwill2022-12-0113716458core:IntangibleAssetsOtherThanGoodwill2022-12-0113716458core:LandBuildings2022-12-0113716458core:PlantMachinery2022-12-0113716458core:Vehicles2022-12-0113716458core:FurnitureFittings2022-12-0113716458core:OfficeEquipment2022-12-0113716458core:AfterOneYear2022-12-0113716458core:WithinOneYear2022-12-0113716458core:ListedExchangeTraded2022-12-0113716458core:UnlistedNon-exchangeTraded2022-12-0113716458core:ShareCapital2022-12-0113716458core:SharePremium2022-12-0113716458core:RevaluationReserve2022-12-0113716458core:OtherReservesSubtotal2022-12-0113716458core:RetainedEarningsAccumulatedLosses2022-12-0113716458core:AfterOneYear2023-12-012024-11-3013716458core:WithinOneYear2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:CostValuation2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3013716458core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3013716458core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3013716458core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3013716458core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3013716458core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3013716458bus:Director12023-12-012024-11-30

CANNACARE CBD LTD

Registered Number
13716458
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2024

CANNACARE CBD LTD
Company Information
for the year from 1 December 2023 to 30 November 2024

Director

INGHAM, Gareth Edward

Registered Address

12 Queens Grove
Keighley
BD21 1AP

Registered Number

13716458 (England and Wales)
CANNACARE CBD LTD
Statement of Financial Position
30 November 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets38,19210,240
8,19210,240
Current assets
Stocks440,00061,500
Cash at bank and on hand3,7446,005
43,74467,505
Creditors amounts falling due within one year5(49,091)(74,598)
Net current assets (liabilities)(5,347)(7,093)
Total assets less current liabilities2,8453,147
Provisions for liabilities6(1,556)(1,946)
Net assets1,2891,201
Capital and reserves
Called up share capital11
Profit and loss account1,2881,200
Shareholders' funds1,2891,201
The financial statements were approved and authorised for issue by the Director on 22 January 2025, and are signed on its behalf by:
INGHAM, Gareth Edward
Director
Registered Company No. 13716458
CANNACARE CBD LTD
Notes to the Financial Statements
for the year ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Vehicles20
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Vehicles

Total

££
Cost or valuation
At 01 December 2316,00016,000
At 30 November 2416,00016,000
Depreciation and impairment
At 01 December 235,7605,760
Charge for year2,0482,048
At 30 November 247,8087,808
Net book value
At 30 November 248,1928,192
At 30 November 2310,24010,240
4.Stocks

2024

2023

££
Finished goods40,00061,500
Total40,00061,500
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security11,0064,619
Other creditors37,43569,380
Accrued liabilities and deferred income650599
Total49,09174,598
6.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)1,5561,946
Total1,5561,946